Full Event Guide

Download the event guide to:

• Discover which preclinical and translational models are best practice for progressing cell therapy candidates
• Explore how to effectively model the tumor microenvironment, regression, and resistance to further MoA understanding and improve predictability
• Leverage classical and next-generation models to gain robust data and guide clinical design

Preclinical and translational oncology continues to progress, and the community continues to grow year on year. To ensure this endures, it is essential to share both challenges and advances.

This is an opportunity to gain need-to-know updates and exciting insights from pioneers of the preclinical and translational oncology field.

Enhance your MoA studies, see best-in-class models for cell and combination therapies, improve translational confidence and predictability and answer critical safety and efficacy questions to aid candidate progression.